Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Upstream Bio Inc. | 2,036,293 | 2,036,293 | 0 | 12,462 | 22,358 | 14.48% | +9,896 |
| Beta Bionics Inc. | 1,988,287 | 1,988,287 | 0 | 24,337 | 28,949 | 18.75% | +4,613 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 1,418 | 2,303 | 1.49% | +886 |
| Lexeo Therapeutics | 1,184,636 | 1,184,636 | 0 | 4,111 | 4,762 | 3.08% | +652 |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | 2,879 | 3,014 | 1.95% | +135 |
| enGene Holdings Inc. *W EXP 10/31/202 | 321,502 | 321,502 | 0 | 193 | 273 | 0.18% | +80 |
| enGene Holdings Inc. COM | 526,357 | 526,357 | 0 | 2,358 | 1,916 | 1.24% | -442 |
| Immunic Inc. | 1,788,160 | 1,788,160 | 0 | 1,949 | 1,248 | 0.81% | -701 |
| Replimune Group(REPL) | 1,975,203 | 1,975,203 | 0 | 19,258 | 18,350 | 11.88% | -909 |
| Nuvation Bio(NUVB) | 13,072,340 | 11,042,728 | -2,029,612 | 23,007 | 21,533 | 13.94% | -1,474 |
| Alumis Inc. | 653,223 | 653,223 | 0 | 4,011 | 1,960 | 1.27% | -2,051 |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | 28,727 | 20,481 | 13.26% | -8,245 |
| Kestra Med Technologies Ltd. SHS | 1,795,893 | 1,645,893 | -150,000 | 44,754 | 27,289 | 17.67% | -17,465 |